Showing 7,321 - 7,340 results of 30,647 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 100 ((we decrease) OR (nn decrease)) ))', query time: 0.81s Refine Results
  1. 7321
  2. 7322

    <i>Kif3a</i> controls renal branching morphogenesis in a GLI3R-dependent manner. by Lijun Chi (196000)

    Published 2013
    “…(T) Quantitation of NCAM-positive structures in N, O and P reveals a significant decrease in <i>Kif3a<sup>−/−UB</sup></i> mice compared to WT and <i>Kif3a<sup>−/−UB</sup></i>;<i>Gli3<sup>Δ699/+</sup></i> mice. (*, P<0.05, **, P<0.01, *** P<0.001). …”
  3. 7323

    Establishment and characterization of a choroid plexus barrier system. by Bethany A. O’Hara (8532741)

    Published 2024
    “…SF was used to measure the rate of penetrance (cm/sec) from the apical to basal chamber over one hour. As TEER increases, penetrance decreases, indicating that a restrictive barrier has formed. …”
  4. 7324

    IGF-1 induces an increase in <i>PRNP</i> expression through the PI3K-Akt-FOXO3a pathway. by Ting Liu (45625)

    Published 2013
    “…(C) and (D) Western blotting showing the relationship between the phosphorylation of FOXO3a and <i>PRNP</i> expression. Treatment with 50 and 100 ng/ml IGF-1 remarkably increased the phosphorylation of FOXO3a in both the SH-SY5Y and HeLa cell lines but caused little variation in the total level of FOXO3a. …”
  5. 7325
  6. 7326
  7. 7327
  8. 7328
  9. 7329
  10. 7330

    Table_5_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
  11. 7331

    Table_4_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
  12. 7332

    DataSheet_1_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasophary... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
  13. 7333

    Table_3_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
  14. 7334

    Table_1_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
  15. 7335

    Table_2_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
  16. 7336
  17. 7337

    DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…A decrease in OS was found in IKZF1<sup>MUT</sup> and CDKN2A/2B<sup>MUT</sup> patients, but the significance was lost after IKZF1<sup>plus</sup> was removed.…”
  18. 7338

    DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…A decrease in OS was found in IKZF1<sup>MUT</sup> and CDKN2A/2B<sup>MUT</sup> patients, but the significance was lost after IKZF1<sup>plus</sup> was removed.…”
  19. 7339
  20. 7340